MRMD Marimed Inc

$-0.01 (-2.56%)

MRMD Stock Analysis Overview

What this means: Marimed Inc (MRMD) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives MRMD a rank of 19. Our methodology considers analysis of the company's financial situation and how it has traded recently. MRMD rank of 19 means that it ranks below 81% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full MRMD report

Marimed Inc (MRMD) Analyst Forecast

Next 12 months ➝Current Price$0.2352-week High$3.0552-week Low$0.10No Forecast Data Available for MRMD
  • Last Price$0.23
  • Previous Close$0.24
  • Change $-0.01
  • Open$0.25
  • Volume3,540,464
  • Avg. Volume (100-day)1,027,309
  • Market Capitalization$54M
  • Days Range $0.22 - $0.28
  • 52-week Range $0.10 - $3.05
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS-0.39
  • Earnings Date
  • SectorHealthcare
  • IndustryBiotechnology
  • Avg. Analyst Rec.
  • Beta-1.76
  • PEG Ratio
  • Volatility0.94
  • Average True Range0.19
MariMed Inc offers turnkey solutions to cannabis cultivators, producers, and dispensaries. It advises its clients in securing cannabis licenses, and in turn, develops and manages, regulatory-compliant facilities for the cultivation, production, and dispensary of legal cannabis. The company also has created a brand of precision-dosed cannabis-infused products, under the brand name Kalm Fusion which are licensed and distributed nationally. It has approximately five active and fully operational facilities in Delaware, Illinois, and Nevada and three facilities under stages of acquisition in Maryland. It has two segments online portal operations and cannabis operations. Maximum revenue is generated from cannabis segment.